New rabies vaccine schedule tested in 2,000 volunteers
NCT ID NCT07357545
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new rabies vaccine given in different schedules after exposure. It involved 2,040 healthy people aged 10-60. The goal was to see if the vaccine triggers a strong immune response and is safe compared to a standard vaccine.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Rabies vaccine (Vero cell), freeze-dried
- What this could lead to
- If successful, this could provide a simpler, effective vaccination schedule for rabies prevention after exposure.
- What could go wrong
- This trial is completed but results are not yet published. The vaccine may not work as well as existing options, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dazhu County Center for Disease Control and Prevention
Dazhou, China
-
Yuechi County Center for Disease Control and Prevention
Guang’an, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Rabies vaccine booster still effective after 5 years, study to confirm
- New rabies shot could shield millions after bites
- Rabies vaccine batch check: will it pass the test?
- New rabies vaccine shows promise in preventing deadly infection
- Promising new rabies vaccine passes phase 3 test
- New rabies vaccine shows promise in large thai trial